Linagliptin and secoisolariciresinol diglucoside attenuate hyperlipidemia and cardiac hypertrophy induced by a high-methionine diet in rats via suppression of hyperhomocysteinemia-induced endoplasmic reticulum stress

Background: Cardiac hypertrophy (CH) is one of the contributing causes of morbidity and mortality. Hyperhomocysteinemia (HHcy) is one of the diseases which may predispose hyperlipidemia and CH. Linagliptin (Lina) and secoisolariciresinol diglucoside (SDG) are known to alleviate a variety of illnesse...

Descripción completa

Detalles Bibliográficos
Autores principales: Jalal, Israa A., Elkhoely, Abeer, Mohamed, Shimaa K., Ahmed, Amany A. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665493/
https://www.ncbi.nlm.nih.gov/pubmed/38026992
http://dx.doi.org/10.3389/fphar.2023.1275730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665493/
https://www.ncbi.nlm.nih.gov/pubmed/38026992
http://dx.doi.org/10.3389/fphar.2023.1275730

Ejemplares similares